missing translation for 'onlineSavingsMsg'
Learn More
Please login to your online account to display your discounted pricing

POU3F2 Monoclonal Antibody, Clone: 6H12, Invitrogen™

POU3F2 Antibody (6H12), MA5-17153, from Invitrogen™. Species Reactivity: Human; Applications: Western Blot.

Manufacturer:  Pierce Biotechnology Inc MA517153

Catalog No. PIMA517153


 

Specifications

Description

POU3F2 Antibody (6H12), MA5-17153, from Invitrogen. Species Reactivity: Human; Applications: Western Blot.

This gene encodes a member of the POU-III class of neural transcription factors. The encoded protein is involved in neuronal differentiation and enhances the activation of corticotropin-releasing hormone regulated genes. Overexpression of this protein is associated with an increase in the proliferation of melanoma cells.
Host Species: Mouse
Cross Reactivity: Human
Isotype: IgG1
Clone: 6H12
Immunogen: Purified recombinant fragment of human POU3F2 (amino acids: 214-362) expressed in E. Coli.
Formulation: 100 ug purified antibody (1mg/mL) in PBS with 0.5% proprietary stabilizer and 0.05% sodium azide
Uniprot Accession: P20265
Entrez GeneID: 5454
Gene Symbol: POU3F2
MA5-17153 targets POU3F2 in pep-ELISA and WB applications and shows reactivity with Human samples. The MA5-17153 immunogen is purified recombinant fragment of human POU3F2 (amino acids: 214-362) expressed in E. Coli. MA5-17153 detects POU3F2 which has a predicted molecular weight of approximately 46.9kDa.
Description & Specifications

Specifications

POU3F2
6H12
Human
100μg purified antibody (1mg/mL) in PBS with 0.5% proprietary stabilizer and 0.05% sodium azide
POU3F2
Purified recombinant fragment of human POU3F2 (amino acids: 214-362) expressed in E. Coli.
100μg
avoiding freeze/thaw cycles.
Monoclonal
Human
Western Blot
Unlabeled
Purified
P20265
Murine
IgG1
Human
Primary
5454
Promotions

Promotions

  • Purchase any three Invitrogen™ Antibodies and receive a fourth antibody at no additional cost. This is an NLSU exclusive offer. You must apply and qualify for the program to be eligible.

    06/30/18